Contrast Media Market Segments, Opportunities and Regional Trends - Exclusive Report by MarketsandMarkets™

-

What is contrast media?

Contrast media is a type of medical imaging contrast agent used to enhance the visibility of internal body structures during medical imaging procedures. Contrast agents are typically injected into the patient intravenously before the imaging procedure. Common types of medical imaging procedures that use contrast media include computed tomography (CT), magnetic resonance imaging (MRI), and angiography.

There are two main types of contrast media: ionic and non-ionic. Ionic contrast media contains iodine, which is absorbed by the body and can cause side effects such as nausea, vomiting, and diarrhea. Non-ionic contrast media does not contain iodine and is less likely to cause side effects.

Why the contrast media market is a good investment opportunity?

The global contrast media market is growing rapidly, due to the increasing use of diagnostic imaging procedures. The major players in this market are GE Healthcare, Bayer AG, and Bracco S.p.A. This article discusses why the contrast media market is a good investment opportunity.

If you're looking for a good investment opportunity, the contrast media market is definitely worth considering. The global market is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911

There are a number of factors driving this growth, including the increasing prevalence of chronic diseases such as cancer and cardiovascular disease, the aging population, and the growing use of computed tomography (CT) and magnetic resonance imaging (MRI).

The contrast agent market is highly consolidated, with the top three players accounting for over 60% of the market. However, there is still room for smaller players to grow, as the market is expected to continue to expand in the coming years.

The global contrast media/ contrast agents market is consolidated. The prominent players operating in this market include GE Healthcare (US), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), J.B. Chemicals and Pharmaceuticals Ltd. (India), Lantheus Medical Imaging, Inc. (US), Unijules Life Sciences Ltd. (India), and SANOCHEMIA Pharmazeutika GmbH (Austria).

What are the risks and benefits of investing in the contrast media market?

The risks and benefits of investing in the contrast agent market are both significant. On the one hand, the market is growing rapidly and is expected to continue doing so. This provides investors with the opportunity to make a profit. On the other hand, there are a number of risks associated with this type of investment. These include the potential for regulatory changes, the possibility of negative publicity, and the potential for new entrants to enter the market and compete with existing companies.

The contrast media market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa (MEA). North America was the largest regional market for contrast agents market in 2020. The large share of the North American market can be attributed to presence of major players in the region, high prevalence of chronic disorders, growing geriatric population, and the increasing adoption of minimally invasive procedures.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more